Confirming you are not from the U.S. or the Philippines

By giving this statement, I explicitly declare and confirm that:
  • I am not a U.S. citizen or resident
  • I am not a resident of the Philippines
  • I do not directly or indirectly own more than 10% of shares/voting rights/interest of the U.S. residents and/or do not control U.S. citizens or residents by other means
  • I am not under the direct or indirect ownership of more than 10% of shares/voting rights/interest and/or under the control of U.S. citizen or resident exercised by other means
  • I am not affiliated with U.S. citizens or residents in terms of Section 1504(a) of FATCA
  • I am aware of my liability for making a false declaration.
For the purposes of this statement, all U.S. dependent countries and territories are equalled to the main territory of the USA. I accept full responsibility for the accuracy of this declaration and commit to personally address and resolve any claims or issues that may arise from a breach of this statement.
We are dedicated to your privacy and the security of your personal information. We only collect emails to provide special offers and important information about our products and services. By submitting your email address, you agree to receive such letters from us. If you want to unsubscribe or have any questions or concerns, write to our Customer Support.
Octa trading broker
Open trading account
Back

USD/JPY extends its three-day gains, steady at around 114.30s

  • The US dollar advances 0.59% in the week vs. the Japanese yen.
  • Higher US T-bond yields rise three basis points close to 1.50%.
  • USD/JPY Price Forecast: It has an upward bias, though accelerating the trend would need a break above 114.70.

The US dollar extends its rally against the Japanese yen, advances for the third consecutive day, trading at 114.36 during the New York session at press time. Positive news on the Covid-19 Omicron-variant front is cheered by investors as the Santa Rally finally kicked in. European equity indices rise between 0.93% and 1.42%, while US stock indices advance between 0.62% and 0.70%.

The US Food and Drug Administration (FDA) has authorized Covid-19 treatments in the last two days. On Wednesday, approved Pfizer’s Plaxovid, treatment for high-risk patients. By Thursday, Molnupravir, a treatment pill developed by Merck, received the green light from the FDA.  Both treatments would help to curb rising infections from overwhelming hospitals.

That said, US T-bond yields rallied on the news, with the 10-year US Treasury yield rising three basis points, closing to 1.50%, underpins the USD/JPY. In the meantime, the US Dollar Index, which tracks the buck’s performance against a basket of six rivals, is barely up 0.03%, up to 96.10.

USD/JPY Price Forecast: Technical outlook

The USD/JPY daily chart depicts the pair has an upward bias, supported by the daily moving averages (DMAs) residing below the spot price. Additionally, an upslope trendline drawn from September swing lows towards late November ones stalled downward moves three times.

To the upside, the USD/JPY first resistance would be the October 20 cycle high at 114.70. A breach of the latter could pave the way for further USD/JPY gains. The next resistance would be the psychological 115.00 figure, followed by the November 24 cycle high and YTD high at 115.52.

On the flip side, the USD/JPY first demand zone would be the 50-DMA at 113.87. A break beneath that support would open the door for a test of the upslope trendline around the 113.60-75 range, followed by the December 17 pivot low at 113.14.

 

Fed to begin raising interest rates by the second half of 2022 – Wells Fargo

Regarding the Federal Reserve, analysts at Wells Fargo, in line with market consensus see a cumulative 125 bps of rate hikes during 2022 and 2023. The
Read more Previous

GBP/USD Price Analysis: Bulls throwing in the towel at weekly resistance

GBP/USD has rallied into a weekly order block from where some meanwhile consolidation would be expected to unfold in the coming sessions. The followin
Read more Next